Insider at

04

Insider transactions

05
0 buys (P) 8 sells (S) Net: $-1,146,626 + 20 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

20 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
April 27, 2026 BCAX S 10b5-1 5,500 $22.88 $125,840 55,286 Direct -9.05% Disposed -22.9% (price as of 2026-10-02)
March 25, 2026 BCAX S 10b5-1 5,500 $18.95 $104,225 55,286 Direct -9.05% Disposed -7.0% (price as of 2026-10-02)
March 4, 2026 BCAX S 10b5-1 16,300 $18.52 $301,876 55,286 Direct -22.77% Disposed -4.8% (price as of 2026-10-02)
March 3, 2026 BCAX S 10b5-1 200 $18.45 $3,690 55,286 Direct -0.36% Disposed -4.4% (price as of 2026-10-02)
Nov. 25, 2025 BCAX S 10b5-1 4,594 $18.84 $86,551 35,497 Direct -11.46% Disposed -6.4% (price as of 2026-10-02)
Nov. 25, 2025 BCAX S 10b5-1 906 $18.84 $17,069 35,497 Direct -2.49% Disposed -6.4% (price as of 2026-10-02)
Nov. 24, 2025 BCAX S 10b5-1 5,500 $18.45 $101,475 35,497 Direct -13.42% Disposed -4.4% (price as of 2026-10-02)
Oct. 9, 2025 BCAX S 10b5-1 22,000 $18.45 $405,900 35,497 Direct -38.26% Disposed -4.4% (price as of 2026-10-02)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
Oct. 1, 2026 PLRX Stock Option (Right to Buy) Common Stock (575,000) $1.05 Oct. 1, 2036 575,000 Acquired
April 27, 2026 BCAX Stock Option (Right to Buy) Common Stock (5,500) $3.79 Aug. 8, 2023 5,500 Disposed
March 25, 2026 BCAX Stock Option (Right to Buy) Common Stock (5,500) $3.79 Aug. 8, 2023 5,500 Disposed
March 4, 2026 BCAX Stock Option (Right to Buy) Common Stock (16,300) $3.79 Aug. 8, 2023 16,300 Disposed
March 3, 2026 BCAX Stock Option (Right to Buy) Common Stock (200) $3.79 Aug. 8, 2023 200 Disposed
Feb. 2, 2026 BCAX Stock Option (Right to Buy) Common Stock (100,000) $16.76 Feb. 2, 2036 100,000 Acquired
Dec. 26, 2025 BCAX Stock Option (Right to Buy) Common Stock (19,789) $3.79 Aug. 8, 2033 19,789 Disposed
Nov. 25, 2025 BCAX Stock Option (Right to Buy) Common Stock (4,594) $3.79 Aug. 8, 2033 4,594 Disposed
Nov. 25, 2025 BCAX Stock Option (Right to Buy) Common Stock (906) $3.79 Aug. 8, 2023 906 Disposed
Nov. 24, 2025 BCAX Stock Option (Right to Buy) Common Stock (5,500) $3.79 Aug. 8, 2033 5,500 Disposed
Oct. 9, 2025 BCAX Stock Option (Right to Buy) Common Stock (22,000) $3.79 Aug. 8, 2033 22,000 Disposed

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 5 holdings

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
Sept. 12, 2024 BCAX Common Stock 35,497 Direct
Sept. 12, 2024 BCAX Stock Option (Right to Buy)→ Common Stock (150,870) 150,870 Direct
Sept. 12, 2024 BCAX Stock Option (Right to Buy)→ Common Stock (70,319) 70,319 Direct
Sept. 12, 2024 BCAX Stock Option (Right to Buy)→ Common Stock (134,892) 134,892 Direct
Sept. 12, 2024 BCAX Stock Option (Right to Buy)→ Common Stock (216,368) 216,368 Direct

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

BCAX

M.D.Chief Medical Officer(5)
Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2025 $525,000 $5,000 · · $170,625 · $8,539 $709,164

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.